Association between C-reactive protein-triglyceride glucose index and depressive symptoms in American adults: results from the NHANES 2005 to 2010
Top Cited Papers
Open Access
- 5 December 2024
- journal article
- research article
- Published by Springer Nature in BMC Psychiatry
- Vol. 24 (1) , 1-13
Abstract
The novel serum C-reactive protein-triglyceride glucose index (CTI) has been identified as an ideal parameter that integrates inflammation and insulin resistance, which are potential mechanisms underlying depressive symptoms. Our research aimed to investigate the association between CTI and depressive symptoms. Our cross-sectional investigation utilized data from the National Health and Nutrition Examination Survey conducted between 2005 and 2010. The integrated CTI was calculated as 0.412 × Ln (C-reactive protein) (mg/dL) + Ln [triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. The severity of depressive symptoms was evaluated through the continuous Patient Health Questionnaire-9 (PHQ-9) scores, and the categorical definition of depressive symptoms (PHQ-9 score ≥ 10) reflected moderate to severe symptoms. Survey-weighted linear and logistic regression models were conducted to establish the correlation between CTI and PHQ-9 scores, and between CTI and depressive symptoms. Moreover, subgroup analyses, interaction tests, and smoothed curve fitting were performed to scrutinize the steadiness of the results. A total of 5,954 participants were enrolled in our study, including 477 with depressive symptoms and 5,477 without. The results revealed a significant positive relationship between CTI and PHQ-9 scores (β: 0.40, 95% CI: 0.25,0.55, p < 0.001) and depressive symptoms (OR: 1.30, 95% CI: 1.06,1.61, p = 0.02). Additionally, individuals in the fourth quartile of CTI exhibited a higher likelihood of depressive symptoms than those in the first quartile (PHQ-9 score: β: 0.83, 95% CI: 0.39,1.26, p < 0.001; depressive symptoms: OR: 2.00, 95% CI:1.19,3.36, p = 0.01). Smooth curve fitting and subgroup analyses consistently demonstrated the positive relationship. Elevated CTI was correlated with a higher risk of depressive symptoms, underscoring CTI as a potential clinical indicator for identifying and stratifying depressive symptoms. Not applicable.Keywords
Funding Information
- the postgraduate Innovation Research and Practice Program of Anhui Medical University (YJS20230122)
- the Nanjing Medical University Changzhou Medical Center Project (CMCB202312)
- Changzhou Municipal Health Commission Major Projects (ZD202306)
This publication has 47 references indexed in Scilit:
- Depression and Suicide Risk ScreeningJAMA, 2023
- Associations of serum vitamin C concentrations with risk of all-cause and cause-specific mortality among individuals with and without type 2 diabetesEuropean Journal of Nutrition, 2023
- Smoking Cessation and Changes in Anxiety and Depression in Adults With and Without Psychiatric DisordersJAMA Network Open, 2023
- Triglyceride–glucose index, Alzheimer's disease plasma biomarkers, and dementia in older adults: The MIND‐China studyAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023
- Internet-Based Cognitive Behavioral Therapy for DepressionJAMA Psychiatry, 2021
- Protein and gene markers of metabolic dysfunction and inflammation together associate with functional connectivity in reward and motor circuits in depressionBrain, Behavior, and Immunity, 2020
- Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedoniaBrain, Behavior, and Immunity, 2020
- Using the 9-Item Patient Health Questionnaire to Screen for and Monitor DepressionJAMA, 2019
- Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depressionExperimental Neurology, 2019
- Income inequality and depression: a systematic review and meta‐analysis of the association and a scoping review of mechanismsWorld Psychiatry, 2018